関連する実験動画
Updated: Feb 16, 2026

10:56
Dual Bioluminescence Imaging of Tumor Progression and Angiogenesis
Published on: August 1, 2019
8.8K
腫瘍血管新生のための治療戦略として,先端内皮細胞の選択的標的化
Byoungmo Kim1, Ha Kyeong Lee1, Zulfikar Azam2
1College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|February 15, 2026
まとめ
私たちは,ドッペルを,新しい血管の成長に不可欠な,内皮の尖端細胞 (TipECs) のターゲッタブルレギュレータとして特定しました. ドッペルを抗体で標的にすることで,TipECsを特異的に枯渇させることで,腫瘍の成長を効果的に減少させ,新しい抗血管新生療法戦略を提供しました.
科学分野:
- 分子生物学は分子生物学である.
- 細胞生物学 細胞生物学
- 腫瘍学 腫瘍学
背景:
- 内皮の尖端細胞 (TipECs) は病理的な新血管化を誘導するが,特定の薬剤を投与可能な標的は欠けている.
- 選択的なマーカーがないため,TipECをターゲットにすることは困難です.
研究 の 目的:
- 内皮の尖端細胞に特異的な新しい薬物投与対象を特定し,特徴づけること.
- 尖端細胞機能と腫瘍血管新生を調節するドッペルの役割を調査する.
主な方法:
- 腫瘍モデルにおけるPRND遺伝子 (ドッペルをコードする) の遺伝的消去.
- 保存されたドッペルモチーフを標的としたモノクローナル抗体の開発と応用.
- 腫瘍における尖茎細胞動態とVEGFR2発現の分析.
主要な成果:
- ドッペル発現は,VEGFR2/Dll4/Src経路経由でTipECの選択,移動を促進し,尖茎細胞動態を調節することが判明しました.
- ドッペルの遺伝子アブレーションは,幹細胞に影響を与えることなく,腫瘍におけるTipEC形成を選択的に減少させた.
- VEGFR2+ TipECsをダウンレギュレーションすることによって,DoppelターゲティングによるTipECsの抗体媒介による減少は,腫瘍の成長を著しく抑制しました.
結論:
- ドッペルは,腫瘍における内皮の先端細胞機能の選択的で薬物投与可能な調節剤である.
- ターゲティング・ドッペルは,がん治療における抗血管新生療法を精製するための有望な戦略です.
関連する概念動画
Mechanism of Angiogenesis
7.0K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.0K
T Cell Activation and Clonal Selection
16.4K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
16.4K
Therapeutic Index
7.0K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
7.0K
What is Natural Selection?
129.9K
Natural selection is an evolutionary process in which individuals with survival-promoting traits reproduce at higher rates. These favorable traits become more common within a population or species. Naturally selected traits initially arise via random genetic mutations. In order for selection to occur, there must be variation within a population, the trait controlling the variation must be heritable, and there must be an evolutionary advantage for variation in the trait.
129.9K
Antibiotic Selection
60.3K
Overview
60.3K
Regulation of Angiogenesis and Blood Supply
3.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.6K

